Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

GeneTether Therapeutics Inc. GNTTF

Full chart Compare
Set alert

Price alert · GNTTF

All alert types
0.01 USD 0.00 (+0.00%)

Aug 7, 2023, 12:45 PM EDT

0.01 Day range 0.01
0.01 52-week range 0.0272

Financial health

Altman Z-Score

-0.32 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.7×
FY 2019: -119×FY 2020: -146×FY 2021: -6.6×FY 2022: -5.4×FY 2023: -0.7×
FY 2019 5y median -6.6× FY 2023
P/S 0.0×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×
FY 2019 5y median 0.0× FY 2023
P/B 0.3×
FY 2019: -1302×FY 2020: -138×FY 2021: 68.5×FY 2022: 5.0×FY 2023: 0.3×
FY 2019 5y median 0.3× FY 2023
P/FCF -1.0×
FY 2019: -110×FY 2020: -156×FY 2021: -14.5×FY 2022: -7.8×FY 2023: -1.0×
FY 2019 5y median -14.5× FY 2023
EV/EBITDA 1.2×
FY 2019: -122×FY 2020: -151×FY 2021: -6.5×FY 2022: -4.3×FY 2023: 1.2×
FY 2019 5y median -6.5× FY 2023
EV/Sales 0.0×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×
FY 2019 5y median 0.0× FY 2023
FCF Yield -102.0%
FY 2019: -0.9%FY 2020: -0.6%FY 2021: -6.9%FY 2022: -12.8%FY 2023: -102.0%
FY 2019 5y median -6.9% FY 2023

Profitability

Gross Margin 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2019 5y median 0.0% FY 2023
Operating Margin 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2019 5y median 0.0% FY 2023
Net Margin 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2019 5y median 0.0% FY 2023
ROE -51.3%
FY 2019: 1073.4%FY 2020: 93.8%FY 2021: -1041.6%FY 2022: -92.4%FY 2023: -51.3%
FY 2019 5y median -51.3% FY 2023
ROIC -55.7%
FY 2019: -734.8%FY 2020: -162.2%FY 2021: -471.0%FY 2022: -92.5%FY 2023: -55.7%
FY 2019 5y median -162.2% FY 2023
ROA -49.9%
FY 2019: -676.7%FY 2020: -160.8%FY 2021: -442.1%FY 2022: -88.2%FY 2023: -49.9%
FY 2019 5y median -160.8% FY 2023

Growth (YoY)

Revenue 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2019 FY 2023
Operating Income 55.7%
FY 2019: 0.0%FY 2020: 18.4%FY 2021: -2174.7%FY 2022: -4.9%FY 2023: 55.7%
FY 2019 FY 2023
EPS (diluted) 57.5%
FY 2019: 0.0%FY 2020: 18.8%FY 2021: -2123.1%FY 2022: -22.8%FY 2023: 57.5%
FY 2019 FY 2023
Free Cash Flow 59.8%
FY 2019: 0.0%FY 2020: 29.3%FY 2021: -972.0%FY 2022: -59.1%FY 2023: 59.8%
FY 2019 FY 2023

Financial Health

Current Ratio 36.6×
FY 2019: 0.6×FY 2020: 0.4×FY 2021: 1.7×FY 2022: 22.2×FY 2023: 36.6×
FY 2019 5y median 1.7× FY 2023
Quick Ratio 36.6×
FY 2019: 0.6×FY 2020: 0.4×FY 2021: 1.7×FY 2022: 23.9×FY 2023: 36.6×
FY 2019 5y median 1.7× FY 2023
Debt / Equity 0.0×
FY 2019: -2.5×FY 2020: -1.6×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×
FY 2019 5y median 0.0× FY 2023
Net Debt / EBITDA 1.8×
FY 2019: -0.1×FY 2020: -1.1×FY 2021: 0.1×FY 2022: 1.0×FY 2023: 1.8×
FY 2019 5y median 0.1× FY 2023
Interest Coverage 0.0×
FY 2019: -169×FY 2020: -71.7×FY 2021: -5805×FY 2022: 0.0×FY 2023: 0.0×
FY 2019 5y median -71.7× FY 2023

Dividends

Dividend Yield 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2019 5y median 0.0% FY 2023
Payout Ratio 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2019 5y median 0.0% FY 2023

Annual · latest fiscal year ends 2023-12-31